Healthcare & Medical Devices
North America animal parasiticides market to garner substantial returns over 2017-2024, driven by a stringent regulatory framework and rising pet adoption
The competitive hierarchy of animal parasiticides market recently witnessed one of the most lucrative partnerships of the year, as Merial signed an alliance with the German pharmaceutical company, Boehringer Ingelheim. Post the successful merger, the latter has apparently decided to expand the production capacity of its animal health manufacturing facility at St. Joseph, which would undoubtedly help the company strengthen its position in animal parasiticides industry. Considering the huge demand for parasiticides and pet products, it has been observed that many other companies have also been attempting to ramp up their product portfolio. Recently, Elanco Companion Animal Health launched a massive product range of parasiticides, designed for preventing heartworm disease, whipworm infection, and flea infestations in puppies and dogs. The growing prevalence of zoonotic diseases in the animals is thus, likely to boost animal parasiticides industry share over the years ahead. As per estimates though, in 2016, animal parasiticides market was worth USD 5 billion.
U.S Animal Parasiticides Market size, by Product, 2013-2024 (USD Million)
Regulatory bodies such as the U.S. Food and Drugs Administration (FDA), it has been observed, are also taking initiatives to promote the manufacturing of eco-friendly products. The U.S. Environmental Protection Agency (EPA) for instance, has instituted the President Green Chemistry Challenge Award to motivate manufacturers for developing environment friendly products, the honor of which would undoubtedly prove to be a major driving force for companies in animal parasiticides industry to focus on safer design and latest technology facilities. Driven by a stringent regulatory framework and the early adoption of neoteric products, North America animal parasiticides market is expected to chart out a lucrative growth path in the ensuing years. In fact, as per the estimates, in 2016, North America animal parasiticides industry covered 25% of the overall share, pertaining to the rise in pet population and animal farming.
In the United States, the FDA is responsible for drafting the regulations for limiting the deployment of pesticides in animal-derived products. The association recommended that pet food needs to be hygienic and should not contain any deleterious residue, which may be injurious to animal health. In accordance with the same, the FDA has enforced certain norms for parasiticide manufacturers, which would have a commendable impact on the product landscape of animal parasiticides market. In addition, the U.S. Department of Agriculture has also undertaken the responsibility for regulating veterinary biologics, prominently used for supplementing and enhancing animal immune system, to enhance their safety, effectiveness, purity, and potency. The initiatives undertaken by regulatory bodies would thus, leave a proportional impact on animal parasiticides industy size.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2114
Taking into account the fierce competition prevalent in animal parasiticides market, most of the animal health companies have been inclining toward the adoption of tried-and-tested growth strategies such as M&As. For instance, MWI Veterinary Supply, Inc., one of the most renowned distributors of animal health packages, recently procured Vetspace Limited. Through this acquisition, MWI aims to upgrade its product portfolio with the help of Vetspace’s cloud based practice management software over the years ahead. Speaking along similar lines, some of the renowned players partaking in animal parasiticides market share are Boehringer Ingelheim, Zoetis, Vetoquinol, Bayer, CEVA Santé Animale, Elanco, Perrigo Company PLC., Merck & Co., and Virbac Corporation.
The commitment of companies toward animal health notwithstanding, regional governments have also been planning to structure guidelines in a bid to enhance livestock farming for breeding and meat. The British Poultry Council for instance, has drafted regulatory codes for chicken farming, which would have a proportional impact on parasiticides market outlook in the years ahead. Considering the extended presence of this business space across developed economies such as those of Europe and North America, major animal health companies have conveniently established their distribution centers in these continents. In fact, MWI Veterinary Supply, Inc., one of the prominent distributors of animal healthcare products, has established a total of twenty-three distribution centers across U.S. and one facility in UK, as on 2014. Another noticeable trend proliferating animal parasiticides market share is that apart from animal health firms, other specialized companies have also been striving to penetrate the business space lately. In terms of revenue, Global Market Insights, Inc., claims animal parasiticides industry size to surpass a valuation of USD 6.5 billion by 2024.
Author Name : Sunil Hebbalkar
Healthcare gamification market to derive maximum revenue via enterprise applications over 2017-2024, China likely to push the regional demand
Healthcare Gamification Market has emerged as one of the most remunerative business spheres of recent times, given the rapidly increasing proliferation of smart technology in the healthcare space. The growing prevalence of chronic diseases across the globe has led to an increased demand for the indulgence of technology in medical care, which has subsequently resulted in the acceptance of gamified models across the healthcare system. A paradigm shift has also been observed in the medical fraternity, to B2C models and outcome-based medicine, which would serve as an impactful driving force for healthcare gamification industry share. An inherent vertical of the medical device spectrum, healthcare gamification market size has observed a massive surge in recent times, while registering a revenue of close to USD 16 billion in 2016.
U.S. Healthcare Gamification Market size, By Game Type, 2013-2024 (USD Billion)
A concise glimpse into the developments underlining healthcare gamification market:
- Aetna Incorporation, one of the most prominent healthcare insurers, implemented the life game platform of Mindbloom to help users understand the significance of healthy living.
- The U.S.-based pharma firm, Pfizer Incorporation, developed Hemocraft, a behavior changing application and an educational tool that helps kids understand the significance of abiding by their hemophilia treatment plan – all by means of a fun gaming atmosphere.
- In yet another breakthrough witnessed across healthcare gamification industry, Melon Health, in 2012, introduced a beta version of Goalpost, a social networking & gaming application designed to help people give up smoking. Reportedly, the app has generated massive awareness among the masses regarding the ill-effects of smoking, which led to 23% of 7000 Goalpost users in New Zealand abandon smoking after twelve weeks.
- Mango health has also developed a gaming application that rewards patients with points, every time they consume medicines post the reminder alerts.
- Reflexion Health makes use of a video feedback technology to rectify the physical movements of the patients by comparing it with the animated models.
- Recently, healthcare gamification market witnessed a collaboration between O.C. Tanner and Virgin Pulse to build wellbeing solutions for employees and promote employee engagement activity. The wellbeing services have been designed to assist individuals form healthy habits and bring about a transformation in their behavior.
- SimplyWell LLC, a key healthcare service provider, was recently acquired by a U.S. based workplace wellness technology firm, Viverae®, in a deal that was touted to mutually benefit both the firms. Through this agreement, SimplyWell’s consumers would be able to take advantage of Viverae’s core services, inclusive of gamified social challenges, iOS & Android mobile applications, and a scientifically proven behavior shifting tool. Viverae®, on the other hand, would expand its product portfolio through this deal and concentrate on enhancing its healthcare services, while simultaneously strengthening its stance in healthcare gamification market.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2124
Healthcare gamification industry has been gaining remarkable traction across myriad geographies. Experts claim China to be one of the heaviest contributors of this domain, given that the region held a substantial share of the overall healthcare gamification market revenue in 2016. The rising adoption of the disease prevention approach rather than the disease curing one by healthcare professionals is expected to impel China healthcare gamification industry size. Furthermore, the region has observed a widespread deployment of smartphone applications to track physical activity in recent times. The healthcare space has also been adopting gamification models on a large scale, which would further impel the profitability landscape of the China market.
South Africa is another region that would most likely emerge as a lucrative growth avenue for healthcare gamification market. The prevalence of chronic ailments such as Ebola and HIV across the country are certain to provide opportunities to healthcare IT companies for exploiting the untapped potential of South Africa healthcare gamification industry.
Mango Health, Microsoft Corporation, Hubbub Health, and Ayogo Health are some of prominent companies that have firmly consolidated their presence in the competitive hierarchy of healthcare gamification market. These firms, cite experts, have been vigorously adopting growth strategies along the likes of contemporary product launches and extensive R&D funding. The unquestioned acceptance of novel technologies across the healthcare sector is certain to impel healthcare gamification industry size in the years, with a target revenue estimation exceeding USD 40 billion by 2024.
Author Name : Dhananjay Punekar
U.S. breast cancer therapeutics market to exhibit remarkable gains over 2017-2024, product differentiation to outline the competitive landscape
Breast cancer therapeutics market has gained an appreciable popularity over the past few years with the advent of novel drugs addressing specific actionable targets. The commercialization potential of the industry is quite evident from the estimates depicted by Global Market Insights Inc., that claims that breast cancer therapeutics market size to exceed a valuation of USD 28 billion by 2024, primarily backed by the increasing patient pool suffering from breast cancer. Statistics depict, worldwide, incidence of breast cancer has witnessed a tremendous surge over the recent years, with an estimated figure of almost 1.7 million new cases being diagnosed yearly. In fact, as per WHO’s updated report of 2015, approximately 520,000 casualties result from breast cancer every year. The aforementioned figures itself are testimony to the huge opportunities that breast cancer therapeutics market is yet to unfold.
U.S. Breast Cancer Therapeutics Market, By Product, 2013 – 2024 (USD Billion)
Speaking along similar lines, it is further prudent to note that U.S. experiences a stronghold in the global breast cancer therapeutics industry, subject to the growing occurrence of breast cancer in America. A latest estimation brought forth by the American Cancer Society for the year 2017 claims that U.S. would witness 63410 cases of CIS (carcinoma in situ) and 252,710 cases of invasive breast cancer this year. The report further states that unfortunately around 40,610 women casualties are likely to result from breast cancer. The massive upsurge in the occurrence of breast cancer has upscaled the demand for high-end breast cancer treatments, leaving a subsequent impact on the regional breast cancer therapeutics market size. U.S, having pegged the title of one of the most profound participants in the global business space, is expected to contribute significantly toward the global breast cancer therapeutics industry share in the ensuing years.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/466
Another vital trend providing a substantial push to breast cancer therapeutics market size is the advancements in healthcare infrastructure. Of late, the expanding healthcare business space is blazing with abundance of innovations by renowned giants who have been incessantly attempting to effectuate commercialization of innovative drugs that prove to be extensively beneficial for the consumers – a trend that is leaving a perpetual impact on the product matrix breast cancer therapeutics market.
As per a recent news snippet, scientists at Institute of Cancer Research, London, have come up with a breakthrough solution for breast cancer patients, which reportedly obliterated all signs of breast cancer in 11% patients within a span of 11 days. The drug was allegedly manufactured by blending two cancer drugs – lapatinib (Tyverb) and trastuzumab (Herceptin), and aided almost 17% of the patients with shrinking of tumors so significantly, that the patients didn’t even require chemotherapy post the drug application.
Lately, the overall breast cancer therapeutics market has been fiercely competitive with the engagement of leading giants such as Roche Diagnostics, Novartis, Eli Lilly, Eisai, AstraZeneca, Celgene, Pfizer, and Sanofi. Product differentiation is a major growth strategy incorporated by these market players. Ongoing developments in clinical trials have led to the emergence of novel therapeutic approaches that identifies and addresses specific biological targets. Though only a fraction of renowned giants offer therapeutics for breast tumor as of now, experts claim, breast cancer therapeutics industry to witness substantial expansion in the coming seven years, characterized by the strong participation by the SMBs toward the development of novel drugs and outcome based solutions. In terms of y-o-y growth, the global breast cancer therapeutics market is estimated to register a CAGR of 9% over 2017-2024.
Author Name : Satarupa De
U.S. oxygen cylinders and concentrators market to witness lucrative proceeds over 2017-2024, rising respiratory disease prevalence to drive the regional demand
Powered by a rather humongous application spectrum in the healthcare fraternity, oxygen cylinders and concentrators industry has witnessed a dramatic proceed over the recent years. Testament of the fact is the billion-dollar valuation attained by this market in 2016. Estimates suggest the global oxygen cylinders and concentrators market to have crossed a revenue of USD 2 billion in the yesteryear. A large credit of this growth goes to the healthcare and medical sector, which indeed is regarded as one of the major application segments of this business space. A rapid rise in the number of patients with respiratory disorders has fueled the demand for oxygen cylinders substantially. As per AAAAI, approximately, 300 million people globally are diagnosed with Asthma out of which almost 250,000 people are succumbed to the disease. Estimates further claim that the number of Asthma patients will further grow by above 100 million by the end of 2025 – another data backing the lucrative roadmap projected for oxygen cylinders and concentrators market.
U.S. Oxygen Cylinders and Concentrators Market size, By Product, 2013-2024 (USD Million)
Another vital trend that is fueling the growth of oxygen cylinders and concentrators industry is the increasing life expectancy of the elderly population. The drift is quite commendable across the U.S., where the overall geriatric population base is expected to surpass 98 million by 2060. Reportedly, the geriatric population then will represent 24% of the overall regional population. This surge will overtly leave a perpetual impact on oxygen cylinders and concentrators industry, as the elderly population is more prone to respiratory disorders such as COPD and Asthma. Asthma has further registered a high occurrence rate in the younger population (10-24 years) with a prevalence of 3%-18%. Allegedly, in the U.S., people aged 65 years and above have also recorded a high prevalence of Asthma – between 4%-10%, predominantly in the females. Speaking along similar lines, these trends also portray the United States as one of the profound growth avenues of oxygen cylinders and concentrators market. In fact, as per the estimates, in the year 2016, U.S. procured 85% of the regional industry share, backed by the huge patient pool suffering from respiratory ailments. As per reliable estimates, more than 10 million of the U.S. population suffer from COPD (Chronic Obstructive Pulmonary Disease).
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2097
Elaborating further about the geographical trends with regards to oxygen cylinders and concentrators market, Asia Pacific will also emerge as one of the prominent growth grounds in the ensuing years. A large geriatric population base prone to respiratory disorder, increasing pollution leading to lung ailments, and rising popularity of adventure water sports are few of the major drivers fueling APAC oxygen cylinders and concentrators market size. As per the estimates, China and India will be the major revenue pockets fueling APAC industry trends.
Speaking of the competitive landscape, the oxygen cylinders and concentrators market is intensely fragmented with a plethora of new entrants sharing the business space. Amidst the intense market share battle, product innovation is projected to be one of the major parameters underlining the sustainability quotient of the industry players. In this regard, the developing economies can prove to be an opportunistic investment spot for the industry players, owing to the huge product demand-supply gap in these regions. Some of the renowned names contending a strong portfolio in oxygen cylinders and concentrators market include Chart Industries, Invacare, Inogen, Catalina Cylinders, Philips, HERSILL, Air Liquide, and Cramer Decker Industries.
However, one of the impeding parameters for the oxygen cylinders and concentrators industry remains the high cost of these devices. In addition, some of the claimed operational hazards associated with improper storage of these devices are also impacting the industry growth trends. Nonetheless, the incessant efforts by the industry players with regards to combating these restraints is set to fuel the market expansion in the coming years. Moreover, the increasing population suffering from respiratory disorders further validates that the oxygen cylinders and concentrators market demand will continue to witness commendable gains, in turn establishing a phenomenal profitability landscape. In terms of revenue, Global Market Insights, Inc. projects the oxygen cylinders and concentrators market size to surpass USD 4.5 billion by 2024.
Author Name : Shikha Sinha
Diagnostics medical electronics market to witness a significant growth over 2017-2024, U.S. to majorly impact the regional revenue
In what can only be construed as an innovation that may impact India medical electronics industry to quite an appreciable extent, Philips, a renowned brand across the electronics sector, has recently launched two new diagnostic instruments, namely, MobileDiagnost Opta and BV Vectra in India. The former, a digital X-ray system, has been designed to find extensive applications in intensive care units and operation theatres. BV Vectra, on the other hand, is a mobile C-arm system that is anticipated to be used in orthopedic surgeries. With the presence of three major electronic equipment manufacturers – Siemens, GR, and Philips, and their objective to manufacture the contemporary ‘Made-in-India’ medical devices, it is anticipated that India medical electronics market will experience a lucrative growth in the years ahead.
Germany Medical Electronics Market Value, By Therapeutics
Bringing forth a slew of product innovations in the market has been touted as major growth strategy for businesses, particularly in the medical electronics industry, given the robust requirement of the healthcare space to enhance operational efficiency and lower medical care expenditure. Kinpo Electronics Incorporation, for example, has recently received the EU certificate that approves its newly launched wearable ECG monitor, called the BC1 patch that apparently helps in the prevention of cardiovascular disease. The medical certification allows the firm to promote BC1 within the European Union. Kinpo is expected to commence the product marketing in key European countries by the third quarter of 2017 under its own brand referred as XYZlife. The device provides real-time monitoring, data pertaining to medical history, and authentic medical reports, in addition to encompassing an exceptional function that helps users to contact physicians during emergencies. Experts cite that the BC1 patch is likely to prompt industry rivals to introduce similar products in the market, that would undeniably impel the product landscape of medical electronics industry.
Get a Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/284
Recently in 2017, Mackenzie Health, a renowned healthcare service provider based in Canada, had collaborated with Epic systems corporation, a U.S. based software developing firm, to introduce a new end-to-end electronic medical record system in Canada. The innovative tool assists medical practitioners in the decision-making process and facilitates speedy access of medical health records, in addition to providing improved medication safety and minimizing error occurrences related to closed loop medication administration & bar code authentication. This medical system is the first of its kind launched across the country and is predicted to have a sizable impact on U.S. medical electronics industry, which apparently held more than 90% of the overall revenue share in 2016.
The competitive landscape of medical electronics market has witnessed numerous M&As since the last few years. In fact, recently, Becton, Dickinson and Company, a leading player across medical technology industry, has declared the acquisition of Caesarea Medical Electronics, a key Israel based player across infusion pump systems industry. The acquisition will help the former expand its infusion pumps product portfolio, thereby facilitating the firm to strengthen its position across medical electronics market.
U.S. has been singled out as one of the most profitable growth avenues across North America medical electronics industry, subject to the large presence of major manufacturers in the region and the extensive deployment of advanced technology. The wide insurance coverage provided under the Affordable Care Act and the appreciable improvements in healthcare infrastructure facilities across the region are certain to provide a positive impetus to U.S. medical electronics market.
Some of the firms partaking in medical electronics market share include Toshiba Corporation, Siemens, GE Healthcare, Medtronic Public Limited Company, and Phillips. Most companies have been reported to be adopting new strategies to expand their business scope, contributing extensively towards medical electronics market revenue. Considering the developments that medical electronics industry is replete with, it comes as no surprise that medical electronics market is slated to hit a revenue margin of over USD 148 billion by 2024.
Author Name : Dhananjay Punekar
U.S. osseointegration implants market to witness phenomenal gains over 2017-2024, Global revenue to surpass USD 7 billion by 2024
The competitive spectrum of osseointegration implants market is replete with product innovations and strategic alliances, which have led to the genesis of a renewed dynamism across this business space. Straumann’s recent product launch is an instance validating the above statement. In April 2017, Straumann Group, a key player across pharmaceutical industry, introduced new premium as well as non-premium teeth-replacement products & services at the international dental show (IDS) 2017 held in Germany. The firm had launched its first ceramic dental implant with a monotype design a few years back. Inspired by the favorable clinical outcomes of this product, the company manufactured a two-piece screw-retained, user-friendly ceramic implant, which is undoubtedly set to bring about a substantial impact on osseointegration implants industry.
Europe Osseointegration Implants Market, By Product (USD Million)
The first quarter of the year 2017 also witnessed Natural Dental Implants AG declaring the launch of its customized tooth replacement tool referred as 3D Printed version of REPLICATE TM Tooth at the IDS 2017. The new tool apparently comprises a titanium root portion and zirconia abutment portion analogous to the earlier commercially accessible version of the REPLICATE Tooth. This is indeed an apt instance demonstrating that osseointegration implants market players have been striving to implement novel product development strategies to expand their existing product portfolio. Given that contemporary technologies help in cost-reduction and value creation, it is imperative that their deployment will provide an impetus to osseointegration implants industry.
Osseointegration implants market has been chronicled in the list of businesses that have depicted astounding growth curves subject to the favorable influence of mergers & acquisitions. This is quite aptly evident from the number of collaborations and M&As this business sphere has been witnessing. In 2016, Zimmer Biomet Holdings Incorporation, a medical device industry major, had declared the acquisition of the Ortho Transmission LLC, a key player across osseointegration implants industry, in a bid to develop new integrated skeletal implant prosthesis products and add to its product line.
Get a Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/2061
In yet another breakthrough that took place in the month of September 2016, Osstell Partners, partaking in implant stability measurement market share, had declared the formation of an alliance with W&H Dentalwerk Burmoos GmbH, a major player in the dental industry. The strategic partnership was formed with the intention of bringing about a slew of innovations in dental implant practices, that would ultimately impact osseointegration implants market expansion.
Osseointegration implants industry has experienced extensive penetration across numerous geographies, with the U.S. standing nearly at the helm of the business. Germany however, has been touted as another lucrative avenue that would create a substantial impact on osseointegration implants market, given the robust healthcare infrastructure facilities and the large presence of key manufacturers in the country.
High dental implant costs and low compensation benefits are two of the most profound restraints that might hinder the growth of osseointegration implants industry. Nonetheless, the contribution of prominent companies such as Zimmer Biomet, Straumann Group, Integrum AB, and Danaher Corporation is expected to overcome the proposed constraints in the wake of technological advancements, which would undeniably carve out a positive growth map for osseointegration implants market.
With the product finding extensive use across dental clinics, hospitals, and ambulatory centers, osseointegration implants market is slated to witness massive gains over the next few years. Estimates claim osseointegration implants industry size to surpass USD 7.8 billion by 2024.
Author Name : Dhananjay Punekar
Hospitals to spur tubeless insulin pump market revenue over 2017-2024, Germany to dominate the regional growth
Germany Tubeless Insulin Pump Market, By Component, 2013 – 2024 (USD Million)
Critical agreements between prominent industry giants have ushered in new developments across tubeless insulin pump industry. Quoting an example, in 2016, Insulet Corporation and Eli Lilly & Company, a U.S. based pharmaceutical giant, had signed a pact to build a new type of OmniPod tubeless insulin delivery system to deliver Lilly’s highly concentrated U200 and U500 insulin formulations. It is undeniable therefore, that collaborations witnessed across the pharmaceutical and healthcare industry can have a major impact on the overall business.
Tubeless insulin pumps find a remarkably high demand over their tubed counterparts across the United States. This, as the experts say, is a key determinant that will facilitate the development of North America tubeless insulin pump market. In 2016 alone, U.S. tubeless insulin pump industry size was pegged at USD 200 million. The region is expected to make notable contributions toward North America tubeless insulin pump market share in the ensuing years.
Get a Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/2032
Brazil tubeless insulin pump market size is slated to expand at a rate of 18% over the coming timeframe. Easy accessibility of tubeless insulin pumps with user-friendly features is expected to expand the product penetration in the region.
Europe is slated to be one of prime hubs for the development of tubeless insulin pump market. This prediction may have perhaps stemmed from the fact that the region is a model instance of highly sophisticated healthcare infrastructure. The robust improvement in healthcare services in addition to the deployment of novel technologies across the healthcare sector are projected to have a significant effect on the growth of Germany tubeless insulin pump market share. The country is expected to dominate the overall industry share in terms of revenue over the coming years.
Tubeless insulin pump industry is projected carve out a profitable growth curve over the coming years, subject to the product’s innumerable benefits. The market has been forecast to have bright growth prospects as is evident from the estimates put forth by a research study – the report apparently states that this market will grow at a rate of 25% over 2017-2024, having attained USD 350 million in 2016.
Tubeless insulin pump market is likely to be constrained by a few essential factors, such as escalating product costs and restricted insurance coverage policies. On these grounds, manufacturers have been striving to reduce equipment costs and make them affordable to attract a wider consumer base. In addition, competitive pricing strategies adopted by the key business players will further help in reducing the costs of devices, thereby propelling tubeless insulin pump market expansion.
Author Name : Dhananjay Punekar